Fulgent Genetics Stock Price, News & Analysis (NASDAQ:FLGT)

$5.02 0.13 (2.66 %)
(As of 01/19/2018 04:00 PM ET)
Previous Close$4.89
Today's Range$4.88 - $5.08
52-Week Range$2.72 - $13.50
Volume46,395 shs
Average Volume27,854 shs
Market Capitalization$89.20 million
P/E Ratio250.25
Dividend YieldN/A
Beta0.21

About Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics logoFulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.

Receive FLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:FLGT
CUSIPN/A
Phone626-350-0537

Debt

Debt-to-Equity RatioN/A
Current Ratio10.17%
Quick Ratio10.17%

Price-To-Earnings

Trailing P/E Ratio250.25
Forward P/E Ratio-83.67
P/E GrowthN/A

Sales & Book Value

Annual Sales$18.27 million
Price / Sales4.90
Cash FlowN/A
Price / CashN/A
Book Value$3.08 per share
Price / Book1.63

Profitability

Trailing EPSN/A
Net Income$-5,340,000.00
Net Margins-0.36%
Return on Equity0.20%
Return on Assets0.18%

Miscellaneous

Employees70
Outstanding Shares17,820,000

Fulgent Genetics (NASDAQ:FLGT) Frequently Asked Questions

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics Inc (NASDAQ:FLGT) issued its quarterly earnings results on Monday, November, 6th. The company reported ($0.05) earnings per share for the quarter. Fulgent Genetics had a negative net margin of 0.36% and a positive return on equity of 0.20%. View Fulgent Genetics' Earnings History.

When will Fulgent Genetics make its next earnings announcement?

Fulgent Genetics is scheduled to release their next quarterly earnings announcement on Monday, February, 26th 2018. View Earnings Estimates for Fulgent Genetics.

Where is Fulgent Genetics' stock going? Where will Fulgent Genetics' stock price be in 2018?

2 brokerages have issued twelve-month price targets for Fulgent Genetics' shares. Their forecasts range from $7.00 to $7.50. On average, they anticipate Fulgent Genetics' stock price to reach $7.25 in the next year. View Analyst Ratings for Fulgent Genetics.

Who are some of Fulgent Genetics' key competitors?

Who are Fulgent Genetics' key executives?

Fulgent Genetics' management team includes the folowing people:

  • Ming Hsieh, Chairman of the Board, President, Chief Executive Officer (Age 61)
  • Paul Kim, Chief Financial Officer (Age 47)
  • Hanlin Gao M.D., Ph.D., Lab Director and Chief Scientific Officer
  • John Bolger, Director
  • James J. Mulay, Director
  • Yun Yen M.D., Ph.D., Director

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,600,000 shares at $12.00-$14.00 per share. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers.

How do I buy Fulgent Genetics stock?

Shares of Fulgent Genetics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fulgent Genetics' stock price today?

One share of Fulgent Genetics stock can currently be purchased for approximately $5.02.

How big of a company is Fulgent Genetics?

Fulgent Genetics has a market capitalization of $89.20 million and generates $18.27 million in revenue each year. Fulgent Genetics employs 70 workers across the globe.

How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]


MarketBeat Community Rating for Fulgent Genetics (FLGT)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  64 (Vote Outperform)
Underperform Votes:  97 (Vote Underperform)
Total Votes:  161
MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Fulgent Genetics (NASDAQ:FLGT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.25$7.25$10.67$13.67
Price Target Upside: 79.01% upside79.01% upside89.13% upside56.37% upside

Fulgent Genetics (NASDAQ:FLGT) Consensus Price Target History

Price Target History for Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics (NASDAQ:FLGT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/7/2017Credit Suisse GroupLower Price TargetOutperform$10.00 -> $7.50N/AView Rating Details
11/7/2017Raymond James FinancialDowngradeOutperform -> Mkt PerformN/AView Rating Details
10/24/2017Piper Jaffray CompaniesReiterated RatingBuyN/AView Rating Details
10/24/2016BTIG ResearchInitiated CoverageBuy$15.00N/AView Rating Details
(Data available from 1/20/2016 forward)

Earnings

Fulgent Genetics (NASDAQ:FLGT) Earnings History and Estimates Chart

Earnings by Quarter for Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics (NASDAQ FLGT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2018        
11/6/2017Q3 2017($0.05)ViewN/AView Earnings Details
8/7/2017Q2 2017$0.02$0.02$5.03 million$4.64 millionViewListenView Earnings Details
5/8/2017Q1 2017$0.03$0.02$5.85 million$5.31 millionViewListenView Earnings Details
2/27/2017Q416$0.04$0.05$5.99 million$5.85 millionViewListenView Earnings Details
11/14/2016Q3 2016$0.08($0.44)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Fulgent Genetics (NASDAQ:FLGT) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.06 EPS
Next Year EPS Consensus Estimate: $-0.11 EPS

Dividends

Dividend History for Fulgent Genetics (NASDAQ:FLGT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Fulgent Genetics (NASDAQ FLGT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 58.80%
Institutional Ownership Percentage: 13.42%
Insider Trades by Quarter for Fulgent Genetics (NASDAQ:FLGT)
Insider Trades by Quarter for Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics (NASDAQ FLGT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2017Ming HsiehInsiderBuy2,000$3.60$7,200.006,549,707View SEC Filing  
11/20/2017Ming HsiehCEOBuy7,259$3.28$23,809.526,540,849View SEC Filing  
11/16/2017Ming HsiehInsiderBuy2,205$3.23$7,122.156,540,849View SEC Filing  
11/14/2017Ming HsiehInsiderBuy10,504$3.30$34,663.20View SEC Filing  
11/13/2017Paul KimCFOSell1,573$3.22$5,065.06View SEC Filing  
11/9/2017Ming HsiehCEOBuy11,520$3.47$39,974.406,506,464View SEC Filing  
8/11/2017Paul KimCFOSell6,134$5.71$35,025.14388,602View SEC Filing  
6/15/2017Ming HsiehInsiderBuy20,000$5.26$105,200.006,482,244View SEC Filing  
6/13/2017Ming HsiehInsiderBuy30,000$4.98$149,400.006,459,944View SEC Filing  
9/30/2016Ming HsiehInsiderBuy1,000,000$9.00$9,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Fulgent Genetics (NASDAQ FLGT) News Headlines

Source:
DateHeadline
Zacks: Fulgent Genetics Inc (FLGT) Receives Average Rating of "Buy" from BrokeragesZacks: Fulgent Genetics Inc (FLGT) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - January 5 at 5:32 PM
 Fulgent Genetics Inc (FLGT) Given Consensus Rating of "Buy" by Brokerages Fulgent Genetics Inc (FLGT) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - January 2 at 9:10 PM
Comparing Nanosphere (NSPH) & Fulgent Genetics (FLGT)Comparing Nanosphere (NSPH) & Fulgent Genetics (FLGT)
www.americanbankingnews.com - December 26 at 8:01 PM
ETFs with exposure to Fulgent Genetics, Inc. : December 26, 2017ETFs with exposure to Fulgent Genetics, Inc. : December 26, 2017
finance.yahoo.com - December 26 at 1:50 PM
Fulgent Genetics, Inc. :FLGT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 22, 2017Fulgent Genetics, Inc. :FLGT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 22, 2017
finance.yahoo.com - December 23 at 6:11 AM
Zacks: Fulgent Genetics Inc (FLGT) Given Consensus Recommendation of "Buy" by AnalystsZacks: Fulgent Genetics Inc (FLGT) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - December 16 at 1:52 AM
 Brokerages Set $7.00 Price Target for Fulgent Genetic (FLGT) Brokerages Set $7.00 Price Target for Fulgent Genetic (FLGT)
www.americanbankingnews.com - December 1 at 3:48 PM
Analyzing Fulgent Genetic (FLGT) & InVivo Therapeutics (NVIV)Analyzing Fulgent Genetic (FLGT) & InVivo Therapeutics (NVIV)
www.americanbankingnews.com - November 26 at 9:24 AM
Reviewing ViewRay (VRAY) and Fulgent Genetic (FLGT)Reviewing ViewRay (VRAY) and Fulgent Genetic (FLGT)
www.americanbankingnews.com - November 24 at 5:12 PM
Ming Hsieh Purchases 7,259 Shares of Fulgent Genetic (FLGT) StockMing Hsieh Purchases 7,259 Shares of Fulgent Genetic (FLGT) Stock
www.americanbankingnews.com - November 21 at 4:40 PM
 Fulgent Genetic (FLGT) Given $7.00 Average Target Price by Analysts Fulgent Genetic (FLGT) Given $7.00 Average Target Price by Analysts
www.americanbankingnews.com - November 16 at 3:52 PM
Fulgent Genetic (FLGT) Insider Acquires $34,663.20 in StockFulgent Genetic (FLGT) Insider Acquires $34,663.20 in Stock
www.americanbankingnews.com - November 15 at 9:32 PM
Fulgent Genetic (FLGT) Downgraded by Zacks Investment ResearchFulgent Genetic (FLGT) Downgraded by Zacks Investment Research
www.americanbankingnews.com - November 13 at 7:08 PM
Fulgent Genetic (FLGT) CEO Buys $39,974.40 in StockFulgent Genetic (FLGT) CEO Buys $39,974.40 in Stock
www.americanbankingnews.com - November 13 at 6:54 PM
Analyzing Digirad Corporation (DRAD) and Fulgent Genetic (FLGT)Analyzing Digirad Corporation (DRAD) and Fulgent Genetic (FLGT)
www.americanbankingnews.com - November 10 at 5:48 PM
Edited Transcript of FLGT earnings conference call or presentation 6-Nov-17 10:00pm GMTEdited Transcript of FLGT earnings conference call or presentation 6-Nov-17 10:00pm GMT
finance.yahoo.com - November 8 at 6:56 AM
Fulgent Genetic (FLGT) Price Target Cut to $7.50 by Analysts at Credit Suisse GroupFulgent Genetic (FLGT) Price Target Cut to $7.50 by Analysts at Credit Suisse Group
www.americanbankingnews.com - November 7 at 10:28 PM
Fulgent Genetic (FLGT) Downgraded by Raymond James Financial, Inc.Fulgent Genetic (FLGT) Downgraded by Raymond James Financial, Inc.
www.americanbankingnews.com - November 7 at 11:33 AM
Fulgent Genetic (FLGT) Issues Quarterly  Earnings ResultsFulgent Genetic (FLGT) Issues Quarterly Earnings Results
www.americanbankingnews.com - November 6 at 10:50 PM
Fulgent Geneticss (FLGT) CEO Ming Hsieh on Q3 2017 Results - Earnings Call TranscriptFulgent Genetics's (FLGT) CEO Ming Hsieh on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 10:38 PM
Fulgent Genetics, Inc. to Host Earnings CallFulgent Genetics, Inc. to Host Earnings Call
finance.yahoo.com - November 6 at 10:38 PM
Fulgent Genetics Reports Third Quarter 2017 Financial ResultsFulgent Genetics Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 6 at 10:38 PM
Fulgent Genetic (FLGT) to Release Earnings on MondayFulgent Genetic (FLGT) to Release Earnings on Monday
www.americanbankingnews.com - October 30 at 1:00 PM
Financial Comparison: GenMark Diagnostics (GNMK) & FULGENT GENETIC (FLGT)Financial Comparison: GenMark Diagnostics (GNMK) & FULGENT GENETIC (FLGT)
www.americanbankingnews.com - October 30 at 5:16 AM
Representatives of Fulgent Genetics to Participate in the Credit Suisse 26th Annual Healthcare ConferenceRepresentatives of Fulgent Genetics to Participate in the Credit Suisse 26th Annual Healthcare Conference
finance.yahoo.com - October 25 at 12:02 AM
Fulgent Genetic (FLGT) Earns Buy Rating from Piper Jaffray CompaniesFulgent Genetic (FLGT) Earns Buy Rating from Piper Jaffray Companies
www.americanbankingnews.com - October 24 at 4:26 PM
Fulgent Genetics to Announce Third Quarter 2017 Financial Results on November 6, 2017Fulgent Genetics to Announce Third Quarter 2017 Financial Results on November 6, 2017
finance.yahoo.com - October 23 at 4:31 PM
ETFs with exposure to Fulgent Genetics, Inc. : October 23, 2017ETFs with exposure to Fulgent Genetics, Inc. : October 23, 2017
finance.yahoo.com - October 23 at 4:30 PM
Analyzing Koninklijke Philips N.V. (PHG) & Fulgent Genetic (FLGT)Analyzing Koninklijke Philips N.V. (PHG) & Fulgent Genetic (FLGT)
www.americanbankingnews.com - October 23 at 6:34 AM
Critical Review: FULGENT GENETIC (FLGT) and The CompetitionCritical Review: FULGENT GENETIC (FLGT) and The Competition
www.americanbankingnews.com - October 15 at 4:28 AM
FULGENT GENETIC (FLGT) & Zeltiq Aesthetics (ZLTQ) Financial ContrastFULGENT GENETIC (FLGT) & Zeltiq Aesthetics (ZLTQ) Financial Contrast
www.americanbankingnews.com - October 13 at 10:32 AM
ETFs with exposure to Fulgent Genetics, Inc. : October 10, 2017ETFs with exposure to Fulgent Genetics, Inc. : October 10, 2017
finance.yahoo.com - October 10 at 4:26 PM
Fulgent Genetic (FLGT) Lifted to "Hold" at Zacks Investment ResearchFulgent Genetic (FLGT) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - October 9 at 7:34 PM
Head to Head Analysis: FULGENT GENETIC (FLGT) & Its CompetitorsHead to Head Analysis: FULGENT GENETIC (FLGT) & Its Competitors
www.americanbankingnews.com - October 8 at 10:38 AM
Fulgent Genetics, Inc. :FLGT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017Fulgent Genetics, Inc. :FLGT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017
finance.yahoo.com - October 2 at 2:33 PM
Critical Comparison: FULGENT GENETIC (FLGT) and Its PeersCritical Comparison: FULGENT GENETIC (FLGT) and Its Peers
www.americanbankingnews.com - September 23 at 6:12 PM
Contrasting Fulgent Genetic (FLGT) & Quidel Corporation (QDEL)Contrasting Fulgent Genetic (FLGT) & Quidel Corporation (QDEL)
www.americanbankingnews.com - September 22 at 10:32 AM
Cogentix Medical (CGNT) versus Fulgent Genetic (FLGT) Financial ReviewCogentix Medical (CGNT) versus Fulgent Genetic (FLGT) Financial Review
www.americanbankingnews.com - September 5 at 8:46 PM
Harvard Bioscience (HBIO) vs. FULGENT GENETIC (FLGT) Head-To-Head AnalysisHarvard Bioscience (HBIO) vs. FULGENT GENETIC (FLGT) Head-To-Head Analysis
www.americanbankingnews.com - September 5 at 4:12 AM
Fulgent Genetic (NASDAQ:FLGT) CFO Sells $35,025.14 in StockFulgent Genetic (NASDAQ:FLGT) CFO Sells $35,025.14 in Stock
www.americanbankingnews.com - August 14 at 11:46 PM
Fulgent Genetics (FLGT) Overweight Rating Reaffirmed at Piper Jaffray CompaniesFulgent Genetic's (FLGT) Overweight Rating Reaffirmed at Piper Jaffray Companies
www.americanbankingnews.com - August 10 at 12:22 AM
Edited Transcript of FLGT earnings conference call or presentation 7-Aug-17 9:00pm GMTEdited Transcript of FLGT earnings conference call or presentation 7-Aug-17 9:00pm GMT
finance.yahoo.com - August 8 at 6:22 PM
Credit Suisse Group Cuts Fulgent Genetic (FLGT) Price Target to $10.00Credit Suisse Group Cuts Fulgent Genetic (FLGT) Price Target to $10.00
www.americanbankingnews.com - August 8 at 11:10 AM
Fulgent Geneticss (FLGT) CEO Ming Hsieh on Q2 2017 Results - Earnings Call TranscriptFulgent Genetics's (FLGT) CEO Ming Hsieh on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 9:11 PM
FULGENT GENETIC (NASDAQ:FLGT) Posts  Earnings ResultsFULGENT GENETIC (NASDAQ:FLGT) Posts Earnings Results
www.americanbankingnews.com - August 7 at 8:08 PM
Fulgent Genetics Reports Second Quarter 2017 Financial ResultsFulgent Genetics Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 7 at 4:11 PM
Fulgent Genetic (NASDAQ:FLGT) to Release Earnings on MondayFulgent Genetic (NASDAQ:FLGT) to Release Earnings on Monday
www.americanbankingnews.com - August 3 at 10:58 AM
Fulgent Genetics to Announce Second Quarter 2017 Financial Results on August 7, 2017Fulgent Genetics to Announce Second Quarter 2017 Financial Results on August 7, 2017
finance.yahoo.com - July 31 at 6:25 PM
Fulgent Genetics: The Next Big Healthcare Stock?Fulgent Genetics: The Next Big Healthcare Stock?
seekingalpha.com - April 8 at 9:46 AM
Short Fulgent Genetics; Major Stock Holders Could Sell At Lock-Up ExpirationShort Fulgent Genetics; Major Stock Holders Could Sell At Lock-Up Expiration
seekingalpha.com - March 17 at 5:31 PM

SEC Filings

Fulgent Genetics (NASDAQ:FLGT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Fulgent Genetics (NASDAQ:FLGT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Fulgent Genetics (NASDAQ FLGT) Stock Chart for Saturday, January, 20, 2018

Loading chart…

This page was last updated on 1/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.